Introduced
Committee
Markup
Reported
Floor
Passed
Enacted
HR.193 119th Congress

Maintaining Innovation and Safe Technologies Act

Status
In Committee
Latest Action
2025-01-03
Sponsor
Schweikert, David (R-Arizona)
Official Source
Investability
27/100
Stage
COMMITTEE
Related Bills
0
Full Text
1,544 chars
Alive
Yes
GovGreed Synthesis ·
Maintaining Innovation and Safe Technologies Act This bill requires the Centers for Medicare & Medicaid Services (CMS) to issue guidance on payment requirements for certain remote monitoring devices (e.g., glucose monitors) under Medicare medical services. Specifically, the CMS must issue guidance on payment requirements for devices that use artificial intelligence components and that transmit information to health care providers.
119 HR 193 IH: Maintaining Innovation and Safe Technologies Act U.S. House of Representatives 2025-01-03 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. I 119th CONGRESS 1st Session H. R. 193 IN THE HOUSE OF REPRESENTATIVES January 3, 2025 Mr. Schweikert introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Ways and Means , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To direct the Secretary of Health and Human Services to issue guidance on payment under the Medicare program for certain items involving artificial intelligence. 1. Short title This Act may be cited as the Maintaining Innovation and Safe Technologies Act . 2. Guidance on Medicare payment for certain items involving artificial intelligence Not later than January 1, 2027, the Secretary of Health and Human Services shall use existing communications mechanisms to issue guidance on requirements for payment under part B of title XVIII of the Social Security Act ( 42 U.S.C. 1395j et seq. ) for remote monitoring devices, such as continuous glucose monitors, that— (1) use an artificial intelligence component (such as a continuous adjustment component); and (2) transmit information to a health care provider for purposes of management and treatment of an individual.
🔒 GovGreed Pro · Trading Intelligence on HR.193 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated recently.
Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records.
GovGreed is not affiliated with the U.S. Government. Not financial advice.